Share this video  

GU Cancers 2023 | Improving the prognosis of prostate cancer

Massimo Lazzeri, MD, PhD, IRCCS Humanitas Research Hospital, Milan, Italy, discusses techniques for improving the prognosis of prostate cancer, including spreading awareness on the genetic risks of prostate cancer, such as alterations in BRCA1 and BRCA2, and screening specific populations for prostate cancer. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.